Combinatory activity of linezolid and levofloxacin with antituberculosis drugs in Mycobacterium tuberculosis - 19/07/18
, Regiane Bertin de Lima Scodro b, c, Aryadne Larissa de Almeida a, Vanessa Pietrowski Baldin a, Sandra Sayuri Nakamura de Vasconcelos a, Vera Lucia Dias Siqueira a, b, Katiany Rizzieri Caleffi-Ferracioli a, b, Paula Aline Zanetti Campanerut-Sá b, Rosilene Fressatti Cardoso a, b, cAbstract |
Setting |
The increase of multidrug and extensively drug resistant Mycobacterium tuberculosis strains turns the search for new tuberculosis (TB) treatment options of paramount importance.
Objective |
In this sense, the present study evaluates the in vitro activity of isoniazid (INH)/rifampicin (RIF)/levofloxacin (LVX) and INH/RIF/linezolid (LNZ) combinations in resistant M. tuberculosis.
Design |
The activities of the combinations were evaluated with M. tuberculosis H37Rv, susceptible and 10 resistant clinical isolates by three-dimensional checkerboard. LVX and LNZ were used as the third drug at fixed ½ and ¼ minimum inhibitory concentration (MIC). INH and RIF were tested at concentrations ranging from 0.0009 μg/mL to 50 μg/mL and 0.0009 μg/mL to 800 μg/mL, respectively. The combinatorial effects were determined by the Fractional Inhibitory Concentration Index (FICI). FICI values ≤ 0.75, 0.75–4 and ≥4 were considered as synergism, indifferent and antagonism, respectively.
Results |
MIC ranged from 0.03 - 6.25 μg/mL for INH, 0.008–100 μg/mL for RIF, 0.12–0.25 μg/mL for LVX and 0.25–0.5 μg/mL for LNZ in the H37Rv and all clinical isolates. INH/RIF/LVX and INH/RIF/LNZ synergisms were observed in 40 and 50% of the resistant M. tuberculosis clinical isolates and better observed for INH and RIF combined to LVX or LNZ at ¼ MIC.
Conclusion |
The present study calls attention for the potential use of INH/RIF/LVX and INH/RIF/LNZ combinations in the treatment of resistant TB.
Le texte complet de cet article est disponible en PDF.Keys words : Mycobacterium tuberculosis, Multidrug-resistant, Three-dimensional checkerboard
Plan
Vol 111
P. 41-44 - juillet 2018 Retour au numéro
Article précédent
- LpqT improves mycobacteria survival in macrophages by inhibiting TLR2 mediated inflammatory cytokine expression and cell apoptosis
- Fengge Li, Lili Feng, Chunyan Jin, Xiaoyu Wu, Lingbo Fan, Sidong Xiong, Yuanshu Dong
- Can colony-forming unit testing be used to extend the shelf life of BCG vaccines?
- Nicole L. Messina, Susie Germano, Rhian Bonnici, Lai-yang Lee, Andrew J. Daley, Andrea Bustamante, Peter Jelfs, Nigel Curtis
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?